Recruitment

Recruitment Status
Completed
Estimated Enrollment
44000

Inclusion Criteria

Aged 18-89 on the index date;
Patients must be continuously enrolled in a health plan during the pre-index period;
Patients must have a prescription for dabigatran or warfarin (this first prescription will be the index date);
...
Aged 18-89 on the index date;
Patients must be continuously enrolled in a health plan during the pre-index period;
Patients must have a prescription for dabigatran or warfarin (this first prescription will be the index date);
Patients must have at least one inpatient, or one physician office visit, emergency room visit with a diagnosis of AF (ICD-9-CM diagnosis code: 427.31in any position) on the index date or during the pre-index period;
Patients must be treatment naive from all OAC use prior to first dabigatran or warfarin prescription;

Exclusion Criteria

Patients with transient causes of AF such as hyperthyroidism, any cardiac surgery, pericarditis, mycoarditis, pulmonary embolism within 3 months prior to their first diagnosis of AF;
Patients with valvular procedures related to the baseline AF diagnosis will be excluded;
Patients with transient causes of AF such as hyperthyroidism, any cardiac surgery, pericarditis, mycoarditis, pulmonary embolism within 3 months prior to their first diagnosis of AF;
Patients with valvular procedures related to the baseline AF diagnosis will be excluded;

Summary

Conditions
Atrial Fibrillation
Type
Observational
Design
Time Perspective: Retrospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Study Design: Retrospective

Study Design: Retrospective

Inclusion Criteria

Aged 18-89 on the index date;
Patients must be continuously enrolled in a health plan during the pre-index period;
Patients must have a prescription for dabigatran or warfarin (this first prescription will be the index date);
...
Aged 18-89 on the index date;
Patients must be continuously enrolled in a health plan during the pre-index period;
Patients must have a prescription for dabigatran or warfarin (this first prescription will be the index date);
Patients must have at least one inpatient, or one physician office visit, emergency room visit with a diagnosis of AF (ICD-9-CM diagnosis code: 427.31in any position) on the index date or during the pre-index period;
Patients must be treatment naive from all OAC use prior to first dabigatran or warfarin prescription;

Exclusion Criteria

Patients with transient causes of AF such as hyperthyroidism, any cardiac surgery, pericarditis, mycoarditis, pulmonary embolism within 3 months prior to their first diagnosis of AF;
Patients with valvular procedures related to the baseline AF diagnosis will be excluded;
Patients with transient causes of AF such as hyperthyroidism, any cardiac surgery, pericarditis, mycoarditis, pulmonary embolism within 3 months prior to their first diagnosis of AF;
Patients with valvular procedures related to the baseline AF diagnosis will be excluded;

Tracking Information

NCT #
NCT02043808
Collaborators
Not Provided
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024